JP2011519871A5 - - Google Patents

Download PDF

Info

Publication number
JP2011519871A5
JP2011519871A5 JP2011507765A JP2011507765A JP2011519871A5 JP 2011519871 A5 JP2011519871 A5 JP 2011519871A5 JP 2011507765 A JP2011507765 A JP 2011507765A JP 2011507765 A JP2011507765 A JP 2011507765A JP 2011519871 A5 JP2011519871 A5 JP 2011519871A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
salt
pharmaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011507765A
Other languages
English (en)
Japanese (ja)
Other versions
JP4790871B2 (ja
JP2011519871A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2009/000611 external-priority patent/WO2009135299A1/en
Publication of JP2011519871A publication Critical patent/JP2011519871A/ja
Publication of JP2011519871A5 publication Critical patent/JP2011519871A5/ja
Application granted granted Critical
Publication of JP4790871B2 publication Critical patent/JP4790871B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011507765A 2008-05-05 2009-05-04 レニン阻害剤としての３，４−置換ピペリジン誘導体 Expired - Fee Related JP4790871B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12652908P 2008-05-05 2008-05-05
US61/126,529 2008-05-05
US18830308P 2008-08-07 2008-08-07
US61/188,303 2008-08-07
PCT/CA2009/000611 WO2009135299A1 (en) 2008-05-05 2009-05-04 3, 4 - substituted piperidine derivatives as renin inhibitors

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2011123054A Division JP5587246B2 (ja) 2008-05-05 2011-06-01 レニン阻害剤としての３，４−置換ピペリジン誘導体
JP2011123057A Division JP5653842B2 (ja) 2008-05-05 2011-06-01 レニン阻害剤としての３，４−置換ピペリジン誘導体

Publications (3)

Publication Number Publication Date
JP2011519871A JP2011519871A (ja) 2011-07-14
JP2011519871A5 true JP2011519871A5 (enExample) 2011-08-25
JP4790871B2 JP4790871B2 (ja) 2011-10-12

Family

ID=41264366

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011507765A Expired - Fee Related JP4790871B2 (ja) 2008-05-05 2009-05-04 レニン阻害剤としての３，４−置換ピペリジン誘導体
JP2011123054A Expired - Fee Related JP5587246B2 (ja) 2008-05-05 2011-06-01 レニン阻害剤としての３，４−置換ピペリジン誘導体
JP2011123057A Expired - Fee Related JP5653842B2 (ja) 2008-05-05 2011-06-01 レニン阻害剤としての３，４−置換ピペリジン誘導体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2011123054A Expired - Fee Related JP5587246B2 (ja) 2008-05-05 2011-06-01 レニン阻害剤としての３，４−置換ピペリジン誘導体
JP2011123057A Expired - Fee Related JP5653842B2 (ja) 2008-05-05 2011-06-01 レニン阻害剤としての３，４−置換ピペリジン誘導体

Country Status (23)

Country Link
US (1) US8889714B2 (enExample)
EP (1) EP2274295B1 (enExample)
JP (3) JP4790871B2 (enExample)
KR (2) KR101403311B1 (enExample)
CN (1) CN102015682B (enExample)
AU (1) AU2009243875B2 (enExample)
BR (1) BRPI0912388A2 (enExample)
CA (1) CA2722734C (enExample)
CO (1) CO6311081A2 (enExample)
CR (1) CR11809A (enExample)
DO (1) DOP2010000329A (enExample)
EA (1) EA020853B1 (enExample)
ES (1) ES2548134T3 (enExample)
IL (1) IL208467A (enExample)
MA (1) MA32296B1 (enExample)
MX (1) MX2010012067A (enExample)
MY (1) MY152042A (enExample)
NI (1) NI201000188A (enExample)
NZ (1) NZ589019A (enExample)
PL (1) PL2274295T3 (enExample)
SG (1) SG192543A1 (enExample)
SV (1) SV2010003723A (enExample)
WO (1) WO2009135299A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3034994A1 (en) 2008-06-03 2009-12-10 Intermune, Inc. Substituted aryl-2 pyridone compounds and use thereof for treating inflammatory and fibrotic disorders
CA2747279A1 (en) * 2008-12-10 2010-06-17 Merck Canada Inc. 3,4 - substituted piperidine derivatives as renin inhibitors
TWI562977B (en) * 2010-11-05 2016-12-21 Bayer Ip Gmbh Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation
UA112897C2 (uk) * 2012-05-09 2016-11-10 Байєр Фарма Акцієнгезелльшафт Біциклічно заміщені урацили та їх застосування для лікування і/або профілактики захворювань
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.
CN107602381B (zh) * 2017-09-11 2021-03-16 陕西莱特光电材料股份有限公司 一种萘甲酸酯类衍生物及其制备方法
CN108033876A (zh) * 2017-12-20 2018-05-15 江汉大学 一种5-溴-2-氯苯甲醛的制备方法
US12459934B2 (en) 2018-11-28 2025-11-04 Basf Se Pesticidal compounds
BR112022021631A2 (pt) 2020-04-28 2022-12-06 Basf Se Compostos, composição, métodos para combater ou controlar pragas invertebradas, para proteger plantas em crescimento e para tratar ou proteger um animal, semente e uso de um composto

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380758A (en) 1991-03-29 1995-01-10 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
US5703073A (en) 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
ATE242213T1 (de) 1995-09-07 2003-06-15 Hoffmann La Roche Neue 4-(oxyalkoxyphenyl)-3-oxy-piperidine zur behandlung von herz- und niereninsuffizienz
US5994294A (en) 1996-02-02 1999-11-30 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
WO1998019672A1 (en) 1996-11-01 1998-05-14 Nitromed Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
IT1295694B1 (it) 1996-11-14 1999-05-27 Nicox Sa Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
IT1292426B1 (it) 1997-06-27 1999-02-08 Nicox Sa Sali nitrati di ace-inibitori
EP1506962B1 (en) 2000-10-20 2008-07-02 Eisai R&D Management Co., Ltd. Nitrogen-containing aromatic heterocycles
CA2483241C (en) 2002-04-29 2011-05-31 Actelion Pharmaceuticals Ltd Novel diazabicyclononene derivatives
CA2490138A1 (en) 2002-06-27 2004-01-08 Actelion Pharmaceuticals Ltd. Novel tetrahydropyridine derivatives as renin inhibitors
US20040204455A1 (en) 2003-04-10 2004-10-14 Cody Wayne Livingston Piperidine derivative rennin inhibitors
CA2521951A1 (en) 2003-04-28 2004-11-11 Actelion Pharmaceuticals Ltd Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
MXPA05011478A (es) 2003-04-29 2005-12-12 Actelion Pharmaceuticals Ltd Derivados de 1,2,3,6-tetrahidropiridina 3,4-disustituidos novedosos.
US20060205768A1 (en) 2003-04-30 2006-09-14 Olivier Bezencon Tropane derivatives and their use as ace inhibitors
CN1780663A (zh) 2003-04-30 2006-05-31 埃科特莱茵药品有限公司 作为肾素抑制剂的新型3－位具有杂原子的9－氮杂双环壬烯衍生物
AU2004234038A1 (en) 2003-04-30 2004-11-11 Actelion Pharmaceuticals Ltd. Azabicyclononene derivatives
WO2004096116A2 (en) 2003-05-02 2004-11-11 Actelion Pharmaceuticals Ltd Diazabicyclononene derivatives
TW200513461A (en) 2003-10-01 2005-04-16 Speedel Experimenta Ag Organische verbindungen
WO2005040120A1 (en) 2003-10-09 2005-05-06 Actelion Pharmaceuticals Ltd Tetrahydropyridine derivatives
US20070142363A1 (en) 2003-10-13 2007-06-21 Actelion Pharmaceuticals Ltd Novel diazabicyclonene derivatives and use thereof
EP1680427A1 (en) 2003-10-23 2006-07-19 Actelion Pharmaceuticals Ltd. Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
WO2005054243A1 (en) 2003-12-05 2005-06-16 Actelion Pharmaceuticals Ltd Diazabicyclononene derivatives and their use as renin inhibitors
CN1890239A (zh) 2003-12-05 2007-01-03 埃科特莱茵药品有限公司 二氮杂二环壬烯及带有新的侧链的四氢吡啶衍生物
TW200613274A (en) * 2004-07-09 2006-05-01 Speedel Experimenta Ag Organic compounds
WO2006021401A2 (en) 2004-08-25 2006-03-02 Actelion Pharmaceuticals Ltd Bicylononene derivatives
US8138340B2 (en) 2004-08-25 2012-03-20 Actelion Pharmaceuticals Ltd. Bicyclononene derivatives
WO2006021399A2 (en) 2004-08-25 2006-03-02 Actelion Pharmaceuticals Ltd Azabicyclononene derivatives as renin inhibitors
WO2006021403A1 (en) 2004-08-25 2006-03-02 Actelion Pharmaceuticals Ltd Bicyclononene derivatives
WO2006058546A1 (en) 2004-12-01 2006-06-08 Actelion Pharmaceuticals Ltd Novel lactame derivatives as renin inhibitors
AR052263A1 (es) 2004-12-08 2007-03-07 Actelion Pharmaceuticals Ltd Derivado de diazabiciclononeno
WO2006063610A1 (en) 2004-12-17 2006-06-22 Actelion Pharmaceuticals Ltd Heteroaryl substituted diazabicyclononene derivatives
GB0428526D0 (en) * 2004-12-30 2005-02-09 Novartis Ag Organic compounds
GB0500784D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
MX2007009004A (es) 2005-01-28 2007-09-14 Actelion Pharmaceuticals Ltd Ciclopropil-(2,3-dimetilbencidamida del acido 7-{4-[2-(2,6-dicloro-4-metilfenoxi) etoxi] fenil}-3,9-diazabiciclo [3.3.31]non-6-en-s-carboxilico como inhbidores de renina para el tratamiento de hipertension.
WO2006092268A1 (en) 2005-03-02 2006-09-08 Actelion Pharmaceuticals Ltd Bicyclic five-membered heteroaryl derivatives and their use as renin inhibitors
GB0504850D0 (en) * 2005-03-09 2005-04-13 Novartis Ag Organic compounds
AR055756A1 (es) 2005-03-31 2007-09-05 Speedel Experimenta Ag Piperidinas sustituidas; procesos de preparacion y su uso como medicamentos
US20090270380A1 (en) 2005-03-31 2009-10-29 Peter Herold 3,4,5-Substituted Piperidines as Renin Inhibitors
GB0510810D0 (en) 2005-05-26 2005-06-29 Novartis Ag Organic compounds
EP1893578A2 (en) 2005-05-27 2008-03-05 Actelion Pharmaceuticals Ltd. Novel piperidine carboxylic acid amide derivatives
GB0511063D0 (en) * 2005-05-31 2005-07-06 Novartis Ag Organic compounds
WO2006131884A2 (en) 2005-06-07 2006-12-14 Actelion Pharmaceuticals Ltd Thiazole substituted diazabicyclononane or-nonene derivatives as renin inhibitors
CA2615048A1 (en) 2005-07-22 2007-01-25 Merck Frosst Canada Ltd. Renin inhibitors
WO2007034406A1 (en) 2005-09-22 2007-03-29 Actelion Pharmaceuticals Ltd Pyrrolidine-3-carboxylic acid amide derivatives and their use as inhibitors of renin
WO2007034445A2 (en) 2005-09-26 2007-03-29 Actelion Pharmaceuticals Ltd Novel piperazine derivatives as renin inhibitors for cardiovascular events and renal insufficiency
WO2007049224A1 (en) 2005-10-25 2007-05-03 Actelion Pharmaceuticals Ltd Novel hexahydro- or octahydro-cyclopenta[c]pyrrole derivatives
US8129411B2 (en) 2005-12-30 2012-03-06 Novartis Ag Organic compounds
EP1816122A3 (en) 2006-01-19 2007-09-19 Speedel Experimenta AG 3,4,5-substituted piperidines as therapeutic compounds
RU2425032C2 (ru) 2006-02-02 2011-07-27 Актелион Фармасьютикалз Лтд Вторичные амины в качестве ингибиторов ренина
KR20080100382A (ko) 2006-03-03 2008-11-17 액테리온 파마슈티칼 리미티드 레닌 저해제로서의 1차 아민
CA2642436A1 (en) 2006-03-08 2007-09-13 Actelion Pharmaceuticals Ltd New amines
WO2008036216A1 (en) 2006-09-18 2008-03-27 Vitae Pharmaceuticals, Inc. Piperidine derivatives as renin inhibitors
WO2008058387A1 (en) * 2006-11-17 2008-05-22 Merck Frosst Canada Ltd. Renin inhibitors
US8343968B2 (en) * 2007-05-24 2013-01-01 Merck Canada Inc. Case of renin inhibitors
AU2008286178A1 (en) 2007-08-07 2009-02-12 Merck Frosst Canada Ltd Renin inhibitors
WO2009070869A1 (en) * 2007-12-04 2009-06-11 Merck Frosst Canada Ltd. Renin inhibitors
US20110152316A1 (en) 2008-05-22 2011-06-23 Austin Chih-Yu Chen 3,4-substituted piperidine derivatives as renin inhibitors
US20120190701A1 (en) 2009-08-18 2012-07-26 Merck Sharp & Dohme Corp. Renin inhibitors

Similar Documents

Publication Publication Date Title
JP2012111758A5 (enExample)
JP2012107057A5 (enExample)
JP2011519871A5 (enExample)
JP2007269812A5 (enExample)
JP2009149903A5 (enExample)
JP2011102971A5 (enExample)
JP2009502793A5 (enExample)
JP2013532130A5 (enExample)
JP2010019854A5 (enExample)
JP2011105738A5 (enExample)
JP2009091351A5 (enExample)
JP2009091350A5 (enExample)
JP2012255926A5 (enExample)
JP2013541578A5 (enExample)
JP2011510079A5 (enExample)
JP2011518833A5 (enExample)
JP2009545527A5 (enExample)
JP2010049241A5 (enExample)
JP2012031285A5 (enExample)
JP2010070692A5 (enExample)
JP2010037339A5 (enExample)
JP2010233885A5 (enExample)
JP2012098270A5 (enExample)
JP2011037885A5 (enExample)
JP2010246466A5 (enExample)